Insider Transactions in Q4 2024 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,997
-0.88%
|
$143,973
$9.97 P/Share
|
|
Nov 20
2024
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,178
-2.84%
|
$82,602
$9.97 P/Share
|
|
Nov 20
2024
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
9,268
-2.71%
|
$83,412
$9.97 P/Share
|
|
Nov 20
2024
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
SELL
Payment of exercise price or tax liability
|
Direct |
10,076
-6.27%
|
$90,684
$9.97 P/Share
|
|
Nov 20
2024
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,477
-2.64%
|
$76,293
$9.97 P/Share
|
|
Nov 14
2024
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,193
+0.17%
|
$28,737
$9.57 P/Share
|
|
Nov 11
2024
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
4,000
-1.22%
|
$36,000
$9.0 P/Share
|